Prescribe to Pharma for Emerging-Markets Growth
Many developed-country health-care firms have deep roots in emerging markets and can be a good way to gain exposure, says Morningstar’s Damien Conover.
Emma Wall: I’m Emma Wall. And here with me today is Morningstar analyst, Damien Conover. Hello, Damien.
Damien Conover: Hi, Emma. Thanks for having me.
Emma Wall does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.